Individuals may well respond otherwise to precisely the same dosage of Semaglutide. elements such as human body weight, metabolism, and also other clinical problems can impact how the human body reacts for the medication. Novo has already secured authorization to increase Wegovy’s label to include it being a cure for cardiovascular circumstances

Ozempic® has not been researched in patients which has a historical past of pancreatitis. think about other antidiabetic therapies in people having a record of pancreatitis. Lilly explained any items promoted as tirzepatide and not Mounjaro or Zepbound weren't produced by the drugmaker and they are not accredited via the U.S. food stuff and Drug